Literature DB >> 24150546

Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma.

Thomas F Pezier1, Iain J Nixon, Anil Joshi, Teresa Guerrero-Urbano, Richard Oakley, Jean-Pierre Jeannon, Ricard Simo.   

Abstract

The increasing use of primary chemoradiation (CRT) for laryngeal squamous cell carcinoma (SCC) means that historical surgical data sets are not representative of the modern laryngectomy patient. We analyse a contemporary total laryngectomy (TL) cohort to identify factors predictive of outcome. This is a retrospective consecutive case note review in a UK tertiary referral centre. Demographic, staging, treatment and outcome data were collected. Oncological outcomes are expressed using the Kaplan-Meier method. The log-rank test was used for univariate analysis and cox regression for multivariate analysis. Sixty consecutive patients between 2003 and 2010 underwent primary TL, 28 including partial pharyngectomy. Median age was 61 years and mean follow-up was 24 months (1-78 months). Thirty six patients died during the study period, 24 of their disease. Of the disease-specific deaths, two occurred peri-operatively, four from local, two from regional and 18 from distant disease [two patients had simultaneous local and distant recurrence (DR)]. Five-year overall survival, disease-specific survival, loco-regional recurrence-free survival and distant recurrence-free survival (DRFS) were 36, 51, 87, 62 %, respectively. Of 17 parameters analysed, pN-stage, extra-capsular spread, a non-cohesive tumour front, thyroid infiltration and involvement of level 6 were significant predictors of disease-specific survival (DSS) on univariate analysis. pN > 1 and the presence of adverse histological features were found to be independent predictors of DSS and DRFS on multivariate analysis. Neither was significantly associated with loco-regional recurrence-free survival. Around half of patients who undergo TL for stage IV SCC will die of disease within 5 years, with most deaths attributable to DR. Surgery provides excellent loco-regional control but patients, especially those with advanced nodal disease and/or adverse histological features, should be thoroughly screened for occult distant disease. Level of evidence 4.

Entities:  

Mesh:

Year:  2013        PMID: 24150546     DOI: 10.1007/s00405-013-2779-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

1.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

Authors:  Henry T Hoffman; Kimberly Porter; Lucy H Karnell; Jay S Cooper; Randall S Weber; Corey J Langer; Kie-Kian Ang; Greer Gay; Andrew Stewart; Robert A Robinson
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

3.  Reexamining the treatment of advanced laryngeal cancer.

Authors:  Kerry D Olsen
Journal:  Head Neck       Date:  2010-01       Impact factor: 3.147

4.  Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.

Authors:  J G Spector; D G Sessions; B H Haughey; K S Chao; J Simpson; S El Mofty; C A Perez
Journal:  Laryngoscope       Date:  2001-06       Impact factor: 3.325

5.  Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection.

Authors:  Russell W Hinerman; William M Mendenhall; Robert J Amdur; Scott P Stringer; Douglas B Villaret; K Thomas Robbins
Journal:  Head Neck       Date:  2002-05       Impact factor: 3.147

6.  Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.

Authors:  Giovanni Franchin; Emilio Minatel; Carlo Gobitti; Renato Talamini; Emanuela Vaccher; Giovanna Sartor; Doriano Politi; Mauro G Trovò; Luigi Barzan
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

Review 7.  Cancer of the larynx.

Authors:  Lisa Licitra; Jacques Bernier; Cesare Grandi; Laura Locati; Marco Merlano; Gemma Gatta; Jean-Louis Lefebvre
Journal:  Crit Rev Oncol Hematol       Date:  2003-07       Impact factor: 6.312

8.  Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx.

Authors:  Jeannette Marie S Matsuo; Snehal G Patel; Bhuvanesh Singh; Richard J Wong; Jay O Boyle; Dennis H Kraus; Ashok R Shaha; Michael J Zelefsky; David G Pfister; Jatin P Shah
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

9.  Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma.

Authors:  Julia de Juan; Jacinto García; Montserrat López; César Orús; Eduard Esteller; Miquel Quer; Xavier León
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-05       Impact factor: 6.223

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  3 in total

1.  Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands.

Authors:  Lilian N Ruiter; Boukje A C van Dijk; Annette H Bruggink; Patricia A H Doornaert; Marielle E P Philippens; Remco de Bree; Carla H van Gils; Stefan M Willems
Journal:  BMC Cancer       Date:  2022-04-22       Impact factor: 4.638

2.  Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.

Authors:  Gorkem Eskiizmir; Gokce Tanyeri Toker; Onur Celik; Kivanc Gunhan; Ayca Tan; Hulya Ellidokuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

3.  Effects of Different Treatment Strategies and Tumor Stage on Survival of Patients with Advanced Laryngeal Carcinoma: A 15-Year Cohort Study.

Authors:  Nima Daneshi; Mohammad Fararouei; Mohammad Mohammadianpanah; Mohammad Zare-Bandamiri; Somayeh Parvin; Mostafa Dianatinasab
Journal:  J Cancer Epidemiol       Date:  2018-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.